Target intelligence / Profile preview

Kelch-like protein 41 (KLHL41)

Target
KLHL41
Molecular classification
Kelch family protein, structural sarcomeric protein, not a receptor, enzyme, or typical drug target
01

Overview

Kelch-like protein 41 (KLHL41) is a muscle-specific, structural protein crucial for the assembly, organization, and maintenance of sarcomeres in skeletal muscle. It acts primarily as a molecular chaperone, preventing aggregation and promoting the stability of the large sarcomeric protein nebulin. KLHL41 achieves this function through poly-ubiquitination-dependent mechanisms distinct from most Kelch family proteins, which more commonly target proteins for degradation. Loss-of-function mutations in KLHL41 cause nemaline myopathy, a severe congenital disorder characterized by abnormal muscle structure, sarcomere disorganization, and early-onset muscle weakness or perinatal lethality[1][2][3][4][5][6]. KLHL41 also interacts with other sarcomeric proteins, including NRAP and filamin-C, but its stabilizing effect is predominantly on nebulin. It is not currently considered a direct therapeutic target, drug receptor, or enzyme.

Other names
Kelch-like protein 41KLHL41KBTBD10KRP1SarcosinKel-like protein 23Kelch repeat and BTB domain-containing protein 10Kelch-related protein 1sarcomeric muscle protein
02

Biological functions

Skeletal muscle developmentSarcomere assembly and maintenanceStabilization of sarcomeric proteins (notably nebulin)Protein chaperone activity
03

Disease associations

Nemaline myopathy (genetic muscle disorder characterized by sarcomeric disarray)Other congenital myopathies (through potential disruption of muscle fiber structure)
04

Biomarkers

KLHL41 mutation (for nemaline myopathy diagnosis/subtyping)

Beyond the preview

Go deeper on Kelch-like protein 41 (KLHL41).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kelch-like protein 41 (KLHL41).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call